Infectious disease news covering outbreaks, vaccines, antimicrobial resistance, and global health surveillance.
Gavi stated that new tuberculosis vaccines expected by 2029 could save over seven million lives if supply is ensured. The global vaccine alliance warned that inadequate financing and demand uncertainty pose risks to rollout and manufacturer capacity investments.
André Picard argues that Canada’s decentralized healthcare system fails to provide consistent access to the shingles vaccine, leaving many seniors vulnerable to severe pain. He advocates for universal public coverage to improve vaccination rates and prevent debilitating health outcomes.
The commentary analyzes WalletHub data revealing significant disparities in US vaccination rates, with New England states leading and Mississippi ranking last. It argues that declining flu and measles vaccination levels, exacerbated by post-pandemic skepticism, are increasing outbreak risks across various states during the current flu season.
Newsweek argues that rising measles cases in the United States reflect a broader crisis of institutional trust rather than just public health failures. The commentary links declining MMR vaccination rates among kindergartners to political skepticism, suggesting that distrust in government institutions is driving medical decisions and sustaining outbreaks despite adequate community immunity thresholds.
Reported cases of gonorrhoea and syphilis in Australia rose by more than 50% over the past decade, with syphilis notification rates increasing by 167% among women. Data from the Kirby Institute highlights disproportionately high STI rates among Aboriginal and Torres Strait Islander populations and urgent public health risks regarding congenital syphilis.
MarketWatch reports that emerging research suggests the Shingrix shingles vaccine may offer secondary health benefits, including reduced risk of heart disease and delayed onset of dementia. The article examines scientific evidence supporting these potential long-term preventative effects beyond preventing shingles.
Paediatricians argue that while diphtheria vaccination remains the strongest protection against severe disease, immunity wanes over time, allowing breakthrough infections in fully vaccinated children. Experts contend that timely booster doses are essential to sustain immunity and control outbreaks within Nigeria's routine immunisation programme.
Vaxart has completed enrollment of approximately 5,400 participants in its BARDA-funded Phase IIb oral COVID-19 vaccine trial. Early safety data showed no serious adverse events, with efficacy results expected in the first half of 2027. The company is also seeking funding for norovirus and influenza programs.
With confirmed bluetongue cases reaching 1,132 nationwide, officials are urging Derbyshire farmers to vaccinate livestock immediately. The exotic virus, spread by midges, has already forced the cancellation of the Dovedale Sheepdog Trials, and veterinarians warn it may become a permanent threat to UK agriculture due to favorable summer conditions.
Pennsylvania physicians are urging both children and adults to receive annual flu, COVID-19, and RSV shots as the fall respiratory illness season approaches. Updated vaccines targeting circulating strains will be available for everyone aged six months and older, following interim clinical considerations issued by the CDC on September 1.